For both cohorts , saxagliptin and metformin in the FDCs were bioequivalent to the individual components , as the limits of the @ % confidence intervals of the geometric least squares mean ratios were contained within the @-@ % bioequivalence limits for the area under the plasma concentration-time curve parameters and within the @-@ % bioequivalence limits for the maximum plasma concentration .